SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ginsberg JP,Woo SY,Johnson ME, et al. Ewing's sarcoma family of tumors: ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors.In:Pizzo PA,Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2002: 973974.
  • 2
    Horowitz M,Malawer MM,DeLaney TF, et al. Total body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol. 1993; 11: 19111918.
  • 3
    Wexler LH,DeLaney TF,Avila N, et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1996; 78: 901911.
  • 4
    Burdach S,Jurgens H,Peters C, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol. 1993; 11: 14821488.
  • 5
    Terek R,Brien E,Marcove R, et al. Treatment of femoral Ewing's sarcoma. Cancer. 1996; 78: 7078.
  • 6
    Bolontrade MF,Zhou RR,Kleinerman ES. Vasculogenesis plays a role in the growth of ewing's sarcoma in vivo. Clin Cancer Res. 2002; 8: 36223627.
  • 7
    Lee TH,Bolontrade MF,Worth LL, et al. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34(+) stem cells into the expanding tumor vasculature. Int J Cancer. 2006; 119: 839846.
  • 8
    Zhou Z,Zhou RR,Guan H, et al. E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model. Mol Cancer Ther. 2003; 2: 13131319.
  • 9
    Guan H,Zhou Z,Wang H, et al. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res. 2005; 11: 26622669.
  • 10
    Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Pediatr Hematol Oncol. 1991; 13: 400413.
  • 11
    Heil G,Hoelzer D,Sanz MA, et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood. 1997; 90: 47104718.
  • 12
    Bradstock K,Matthews J,Young G, et al. Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. Leukemia. 2001; 15: 13311338.
  • 13
    Usuki K,Urabe A,Masaoka T, et al. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. Br J Haematol. 2002; 116: 103112.
  • 14
    Crawford J,Ozer H,Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991; 325: 164170.
  • 15
    Freyer G,Ligneau B,Trillet-Lenoir V. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia. Int J Antimicrob Agents. 1998; 10: 39.
  • 16
    Geng D,Joshi SK,Podolsky R, et al. GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells. Mol Immunol. 2007; 44: 521529.
  • 17
    Bussolino F,Colotta F,Bocchietto E, et al. Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells. Int J Clin Lab Res. 1993; 23: 812.
  • 18
    Bussolino F,Ziche M,Wang JM, et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest. 1991; 87: 986995.
  • 19
    Calhoun DA,Christensen RD. Human developmental biology of granulocyte colony-stimulating factor. Clin Perinatol. 2000; 27: 559576.
  • 20
    Tachibana M,Murai M. G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review. Cytokines Cell Mol Ther. 1998; 4: 113120.
  • 21
    Mueller MM,Fusenig NE. Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer. 1999; 83: 780789.
  • 22
    Steube KG,Meyer C,Drexler HG. Constitutive secretion of hematopoietic cytokines by human carcinoma cell lines and its up-regulation by interleukin-1 and phorbol ester. Oncol Rep. 1999; 6: 427432.
  • 23
    Yang EX,Liu F,Xu Z, et al. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad Med J. 2005; 81: 333337.
  • 24
    Noda I,Fujieda S,Ohtsubo T, et al. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer. 1999; 80: 7884.
  • 25
    Mattei S,Colombo MP,Melani C, et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer. 1994; 56: 853857.
  • 26
    Savarese TM,Mitchell K,McQuain C, et al. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett. 2001; 162: 105115.
  • 27
    Braun B,Lange M,Oeckler R, et al. Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization. J Neurooncol. 2004; 68: 131140.
  • 28
    Mueller MM,Herold-Mende CC,Riede D, et al. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol. 1999; 155: 15571567.
  • 29
    Jordan JP,Hand CM,Markowitz RS, et al. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J Neuroncol. 1992; 14: 1935.
  • 30
    Natori T,Sata M,Washida M, et al. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun. 2002; 297: 10581061.
  • 31
    Obermueller E,Vosseler S,Fusenig NE, et al. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res. 2004; 64: 78017812.
  • 32
    Okazaki T,Ebihara S,Asada M, et al. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int Immunol. 2006; 18: 19.
  • 33
    Hirbe H,Uluckan O,Morgan E, et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood. 2007; 109: 34243431.
  • 34
    Lombaert IM,Wierenga PK,Kok T, et al. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res. 2006; 12: 18041812.
  • 35
    Nienaber CA,Petzsch M,Kleine HD, et al. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med. 2003; 3: S73S77.
  • 36
    Kawada H,Takizawa S,Takanashi T, et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation. 2006; 113: 701710.
  • 37
    Hicklin DJ,Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23: 10111027.
  • 38
    Browder T,Butterfield CE,Kraling BM, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 2000; 60: 18781886.
  • 39
    Paris F,Fuks Z,Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001; 293: 293297.